FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Barney Graham

Research Profile

Disorders

Living Beings

Chemicals & Drugs

Anatomy

Procedures

Co-author Network

Publications

TOP 3
Joseph P Casazza; Mary E Enama; Ingelise J Gordon; Emma Gostick; Raphael Gottardo; Barney S Graham; Mary F Kearney; Richard A Koup; Julie E Ledgerwood; Frank M Maldarelli; Martha C Nason; Deborah Persaud; David A Price; Mario Roederer; Emily C Smith; Ann Wiegand; Carrie Ziemniak; Selorm Adzaku; David R Ambrozak; Charla A Andrews; Robert T Bailer; Kathryn A Bowman
Therapeutic Vaccination Expands and Improves the Function of the HIV-Specific Memory T-Cell Repertoire.
Barney S Graham; Richard A Koup; Julie E Ledgerwood; John R Mascola; Gary Nabel; Martha C Nason; Sheila A Peel; Sarah A Plummer; Mario Roederer; Robert T Bailer; Mary E Enama; Ingelise J Gordon
DNA vaccine delivered by a needle-free injection device improves potency of priming for antibody and CD8+ T-cell responses after rAd5 boost in a randomized clinical trial.
Nicolas Cuburu; Christopher B Buck; Patricia M Day; Barney S Graham; Rhonda C Kines; Douglas R Lowy; Yuk-Ying S Pang; John T Schiller
Intravaginal immunization with HPV vectors induces tissue-resident CD8+ T cell responses.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Barney Graham (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Joseph P Casazza; Mary E Enama; Ingelise J Gordon; Emma Gostick; Raphael Gottardo; Barney S Graham; Mary F Kearney; Richard A Koup; Julie E Ledgerwood; Frank M Maldarelli; Martha C Nason; Deborah Persaud; David A Price; Mario Roederer; Emily C Smith; Ann Wiegand; Carrie Ziemniak; Selorm Adzaku; David R Ambrozak; Charla A Andrews; Robert T Bailer; Kathryn A Bowman
Therapeutic Vaccination Expands and Improves the Function of the HIV-Specific Memory T-Cell Repertoire.
The Journal of infectious diseases 2013;207(12):1829-40.
2013: Barney S Graham; Richard A Koup; Julie E Ledgerwood; John R Mascola; Gary Nabel; Martha C Nason; Sheila A Peel; Sarah A Plummer; Mario Roederer; Robert T Bailer; Mary E Enama; Ingelise J Gordon
DNA vaccine delivered by a needle-free injection device improves potency of priming for antibody and CD8+ T-cell responses after rAd5 boost in a randomized clinical trial.
PloS one 2013;8(4):e59340.
2012: Nicolas Cuburu; Christopher B Buck; Patricia M Day; Barney S Graham; Rhonda C Kines; Douglas R Lowy; Yuk-Ying S Pang; John T Schiller
Intravaginal immunization with HPV vectors induces tissue-resident CD8+ T cell responses.
The Journal of clinical investigation 2012;122(12):4606-20.
2012: J E Ledgerwood; John R Mascola; Gary Nabel; M B Pearce; S Plummer; T M Tumpey; G Yamshchikov; Robert T Bailer; Mary E Enama; I J Gordon; Barney S Graham; Z Hu; Richard A Koup
Influenza virus h5 DNA vaccination is immunogenic by intramuscular and intradermal routes in humans.
Clinical and vaccine immunology : CVI 2012;19(11):1792-7.
2012: Teresa R Johnson; Jason S McLellan; Barney S Graham
Respiratory syncytial virus glycoprotein G interacts with DC-SIGN and L-SIGN to activate ERK1 and ERK2.
Journal of virology 2012;86(3):1339-47.
2011: Anne W Rimoin; Barney S Graham
Whither monkeypox vaccination.
Vaccine 2011;29 Suppl 4():D60-4.
2011: Tracy J Ruckwardt; Paul Thomas; Pradyot Dash; Emma Gostick; Allison M W Malloy; Jennifer L McClaren; David A Price; Barney S Graham
Neonatal CD8 T-cell hierarchy is distinct from adults and is influenced by intrinsic T cell properties in respiratory syncytial virus infected mice.
PLoS pathogens 2011;7(12):e1002377.
2011: Barney S Graham
Future opportunities for passive immunity against viral diseases.
The Journal of infectious diseases 2011;204(11):1648-50.
2011: Lindsey R Baden; Dan H Barouch; William A Blattner; Kara Brandariz; Massimo Cardinali; Olivier D Defawe; Raphael Dolin; Barney S Graham; Yunda Huang; Nidhi Kochar; M Juliana McElrath; Cecilia Morgan; Nina Russell; Magdalena E Sobieszczyk; Georgia D Tomaras
Timing of plasmid cytokine (IL-2/Ig) administration affects HIV-1 vaccine immunogenicity in HIV-seronegative subjects.
The Journal of infectious diseases 2011;204(10):1541-9.
2011: Stephen C De Rosa; Allan deCamp; Barney S Graham; Yunda Huang; Spyros A Kalams; Chuen-Yen Lau; M Juliana McElrath; Cecilia Morgan; Gary Nabel; Evan P Thomas; Georgia D Tomaras; Rafi Ahmed; Rama Akondy; John Bui
HIV-DNA priming alters T cell responses to HIV-adenovirus vaccine even when responses to DNA are undetectable.
Journal of immunology (Baltimore, Md. : 1950) 2011;187(6):3391-401.
2011: Yuxing Li; Mark K Louder; Dennis R Burton; Yu Feng; Barney S Graham; Javier Guenaga; Barton F Haynes; Julie E Ledgerwood; Krisha McKee; Sijy O'Dell; Stephen D Schmidt; Laura M Walker; Xueling Wu; Richard Wyatt; John R Mascola
Mechanism of neutralization by the broadly neutralizing HIV-1 monoclonal antibody VRC01.
Journal of virology 2011;85(17):8954-67.
2011: Jason S McLellan; Yongping Yang; Barney S Graham; Peter D Kwong
Structure of respiratory syncytial virus fusion glycoprotein in the postfusion conformation reveals preservation of neutralizing epitopes.
Journal of virology 2011;85(15):7788-96.
2011: Jason S McLellan; Bruno E Correia; Man Chen; Yongping Yang; Barney S Graham; William R Schief; Peter D Kwong
Design and characterization of epitope-scaffold immunogens that present the motavizumab epitope from respiratory syncytial virus.
Journal of molecular biology 2011;409(5):853-66.
2011: Julie E Ledgerwood; Theodore C Pierson; Sarah A Hubka; Niraj Desai; Steve Rucker; Ingelise J Gordon; Mary E Enama; Steevenson Nelson; Martha Nason; Wenjuan Gu; Nikkida Bundrant; Richard A Koup; Robert T Bailer; John R Mascola; Gary Nabel; Barney S Graham
A West Nile virus DNA vaccine utilizing a modified promoter induces neutralizing antibody in younger and older healthy adults in a phase I clinical trial.
The Journal of infectious diseases 2011;203(10):1396-404.
2011: Padma Billam; Kathryn L Bonaparte; Jie Liu; Tracy J Ruckwardt; Man Chen; Alex B Ryder; Rui Wang; Pradyot Dash; Paul Thomas; Barney S Graham
T Cell receptor clonotype influences epitope hierarchy in the CD8+ T cell response to respiratory syncytial virus infection.
The Journal of biological chemistry 2011;286(6):4829-41.
2011: Beryl A Koblin; Chuen-Yen Lau; M Juliana McElrath; David C Montefiori; Cecilia Morgan; Li Qin; Lilian Saavedra; Georgia D Tomaras; Zhixue Maggie Wang; Lindsey Baden; Martin Casapía; Olivier D Defawe; Paul Goepfert; Barney S Graham
Safety and immunogenicity of an HIV adenoviral vector boost after DNA plasmid vaccine prime by route of administration: a randomized clinical trial.
PloS one 2011;6(9):e24517.
2011: Valeria Judkowski; Kingyee Law; Patricia Norori; Jon R Appel; Alcinette Bunying; Daniel C Douek; Feng Ge; Giulianotti Marc; Barney S Graham; Claudia Raja Gabaglia; Radleigh G Santos; Atima Sharma; Mark K Slifka; Clemencia Pinilla
GM-CSF production allows the identification of immunoprevalent antigens recognized by human CD4+ T cells following smallpox vaccination.
PloS one 2011;6(9):e24091.
2011: Gavin J Churchyard; Lawrence Corey; Stephen C De Rosa; Olivier Defawe; Raphael Dolin; J Peter Figueroa; Paul Goepfert; Barney S Graham; Glenda Gray; Doug Grove; John Hural; Spyros Kalams; Artur Kalichman; Michael C Keefer; Michelle Lally; M Juliana McElrath; David C Montefiori; Zoe Moodie; Cecilia Morgan; Gary Nabel; Jean Pape; Mauro Schechter; Georgia D Tomaras; Elizabeth Adams; Lindsey R Baden; Linda-Gail Bekker; William A Blattner
A phase IIA randomized clinical trial of a multiclade HIV-1 DNA prime followed by a multiclade rAd5 HIV-1 vaccine boost in healthy adults (HVTN204).
PloS one 2011;6(8):e21225.
2011: Teresa Johnson; Christina N Johnson; Kizzmekia S Corbett; Gretchen C Edwards; Barney S Graham
Primary human mDC1, mDC2, and pDC dendritic cells are differentially infected and activated by respiratory syncytial virus.
PloS one 2011;6(1):e16458.
2011: Barney S Graham
Biological challenges and technological opportunities for respiratory syncytial virus vaccine development.
Immunological reviews 2011;239(1):149-66.
2011: Richard A Koup; Barney S Graham; Daniel C Douek
The quest for a T cell-based immune correlate of protection against HIV: a story of trials and errors.
Nature reviews. Immunology 2011;11(1):65-70.
2010: J E Ledgerwood; P Costner; N Desai; L Holman; Mary E Enama; G Yamshchikov; S Mulangu; Z Hu; Charla A Andrews; R A Sheets; Richard A Koup; Mario Roederer; Robert T Bailer; John R Mascola; Maria G Pau; Nancy J Sullivan; Jaap Goudsmit; Gary Nabel; Barney S Graham
A replication defective recombinant Ad5 vaccine expressing Ebola virus GP is safe and immunogenic in healthy adults.
Vaccine 2010;29(2):304-13.
2010: Jason S McLellan; Man Chen; Jung-San Chang; Yongping Yang; Albert Kim; Barney S Graham; Peter D Kwong
Structure of a major antigenic site on the respiratory syncytial virus fusion glycoprotein in complex with neutralizing antibody 101F.
Journal of virology 2010;84(23):12236-44.
2010: Tracy J Ruckwardt; Cindy Luongo; Allison M W Malloy; Jie Liu; Man Chen; Peter L Collins; Barney S Graham
Responses against a subdominant CD8+ T cell epitope protect against immunopathology caused by a dominant epitope.
Journal of immunology (Baltimore, Md. : 1950) 2010;185(8):4673-80.
2010: Jie Liu; Tracy J Ruckwardt; Man Chen; John D Nicewonger; Teresa Johnson; Barney S Graham
Epitope-specific regulatory CD4 T cells reduce virus-induced illness while preserving CD8 T-cell effector function at the site of infection.
Journal of virology 2010;84(20):10501-9.
2010: Anne W Rimoin; Prime M Mulembakani; Sara C Johnston; James O Lloyd Smith; Neville K Kisalu; Timothee L Kinkela; Seth Blumberg; Henri A Thomassen; Brian L Pike; Joseph N Fair; Nathan D Wolfe; Robert L Shongo; Barney S Graham; Pierre Formenty; Emile Okitolonda; Lisa E Hensley; Hermann Meyer; Linda L Wright; Jean-Jacques Muyembe
Major increase in human monkeypox incidence 30 years after smallpox vaccination campaigns cease in the Democratic Republic of Congo.
Proceedings of the National Academy of Sciences of the United States of America 2010;107(37):16262-7.
2010: Hannah Kibuuka; Robert Kimutai; Leonard Maboko; Fred Sawe; Mirjam S Schunk; Arne Kroidl; Douglas Shaffer; Leigh Anne Eller; Rukia Kibaya; Michael A Eller; Karin B Schindler; Alexandra Schuetz; Monica Millard; Jason Kroll; Len Dally; Michael Hoelscher; Robert Bailer; Josephine H Cox; Mary Marovich; Deborah L Birx; Barney S Graham; Nelson L Michael; Mark de Souza; Merlin L Robb
A phase 1/2 study of a multiclade HIV-1 DNA plasmid prime and recombinant adenovirus serotype 5 boost vaccine in HIV-Uninfected East Africans (RV 172).
The Journal of infectious diseases 2010;201(4):600-7.
2010: Jason S McLellan; Man Chen; Albert Kim; Yongping Yang; Barney S Graham; Peter D Kwong
Structural basis of respiratory syncytial virus neutralization by motavizumab.
Nature structural & molecular biology 2010;17(2):248-50.
2010: Laurence Peiperl; Cecilia Morgan; Zoe Moodie; Hongli Li; Nina Russell; Barney S Graham; Georgia D Tomaras; Stephen C De Rosa; M Juliana McElrath
Safety and immunogenicity of a replication-defective adenovirus type 5 HIV vaccine in Ad5-seronegative persons: a randomized clinical trial (HVTN 054).
PloS one 2010;5(10):e13579.
2010: Barney S Graham; M Juliana McElrath; Michael C Keefer; Kyle Rybczyk; David Berger; Kent J Weinhold; Janet Ottinger; Guido Ferarri; David C Montefiori; Don Stablein; Carol Smith; Richard Ginsberg; John Eldridge; Ann Duerr; Patricia Fast; Barton F Haynes
Immunization with cocktail of HIV-derived peptides in montanide ISA-51 is immunogenic, but causes sterile abscesses and unacceptable reactogenicity.
PloS one 2010;5(8):e11995.
2010: Eric S Rosenberg; Barney S Graham; Ellen S Chan; Ronald J Bosch; Vicki Stocker; Janine Maenza; Martin Markowitz; Susan Little; Paul E Sax; Ann C Collier; Gary Nabel; Suzanne Saindon; Theresa Flynn; Daniel Kuritzkes; Dan H Barouch
Safety and immunogenicity of therapeutic DNA vaccination in individuals treated with antiretroviral therapy during acute/early HIV-1 infection.
PloS one 2010;5(5):e10555.
2010: Richard A Koup; Mario Roederer; Laurie Lamoreaux; Jennifer Fischer; Laura Novik; Martha C Nason; Brenda D Larkin; Mary E Enama; Julie E Ledgerwood; Robert T Bailer; John R Mascola; Gary Nabel; Barney S Graham
Priming immunization with DNA augments immunogenicity of recombinant adenoviral vectors for both HIV-1 specific antibody and T-cell responses.
PloS one 2010;5(2):e9015.
2010: Cheng Cheng; Jason G D Gall; Martha Nason; C Richter King; Richard A Koup; Mario Roederer; M Juliana McElrath; Cecilia A Morgan; Gavin Churchyard; Lindsey R Baden; Ann C Duerr; Michael C Keefer; Barney S Graham; Gary Nabel
Differential specificity and immunogenicity of adenovirus type 5 neutralizing antibodies elicited by natural infection or immunization.
Journal of virology 2010;84(1):630-8.
2009: Barney S Graham
What does the report of the USMHRP Phase III study in Thailand mean for HIV and for vaccine developers?
Clinical and experimental immunology 2009;158(3):257-9.
2009: Julie E Ledgerwood; Barney S Graham
DNA vaccines: a safe and efficient platform technology for responding to emerging infectious diseases.
Human vaccines 2009;5(9):623-6.
2009: Richard A Koup; Laurie Lamoreaux; David Zarkowsky; Robert T Bailer; C Richter King; Jason G D Gall; Douglas E Brough; Barney S Graham; Mario Roederer
Replication-defective adenovirus vectors with multiple deletions do not induce measurable vector-specific T cells in human trials.
Journal of virology 2009;83(12):6318-22.
2009: Teresa Johnson; SRINIVAS RAO; Robert A Seder; Man Chen; Barney S Graham
TLR9 agonist, but not TLR7/8, functions as an adjuvant to diminish FI-RSV vaccine-enhanced disease, while either agonist used as therapy during primary RSV infection increases disease severity.
Vaccine 2009;27(23):3045-52.
2009: Katie L Davis; Elin S Gray; Penny L Moore; Julie M Decker; Aidy Salomon; David C Montefiori; Barney S Graham; Michael C Keefer; Abraham Pinter; Lynn Morris; Beatrice H Hahn; George M Shaw
High titer HIV-1 V3-specific antibodies with broad reactivity but low neutralizing potency in acute infection and following vaccination.
Virology 2009;387(2):414-26.
2009: Nancy J Sullivan; Julie E Martin; Barney S Graham; Gary Nabel
Correlates of protective immunity for Ebola vaccines: implications for regulatory approval by the animal rule.
Nature reviews. Microbiology 2009;7(5):393-400.
2009: Jie Liu; Tracy J Ruckwardt; Man Chen; Teresa Johnson; Barney S Graham
Characterization of respiratory syncytial virus M- and M2-specific CD4 T cells in a murine model.
Journal of virology 2009;83(10):4934-41.
2009: Sylvain Cecchini; Alejandro Negrete; Tamas Virag; Barney S Graham; Jeffrey I Cohen; robert kotin
Evidence of prior exposure to human bocavirus as determined by a retrospective serological study of 404 serum samples from adults in the United States.
Clinical and vaccine immunology : CVI 2009;16(5):597-604.
2009: Tracy J Ruckwardt; Kathryn L Bonaparte; Martha C Nason; Barney S Graham
Regulatory T cells promote early influx of CD8+ T cells in the lungs of respiratory syncytial virus-infected mice and diminish immunodominance disparities.
Journal of virology 2009;83(7):3019-28.
2008: Julie E Martin; Mark K Louder; LaSonji A Holman; Ingelise J Gordon; Mary E Enama; Brenda D Larkin; Charla A Andrews; Leatrice Vogel; Richard A Koup; Mario Roederer; Robert T Bailer; Phillip L Gomez; Martha Nason; John R Mascola; Gary Nabel; Barney S Graham
A SARS DNA vaccine induces neutralizing antibody and cellular immune responses in healthy adults in a Phase I clinical trial.
Vaccine 2008;26(50):6338-43.
2008: Teresa Johnson; Marc E Rothenberg; Barney S Graham
Pulmonary eosinophilia requires interleukin-5, eotaxin-1, and CD4+ T cells in mice immunized with respiratory syncytial virus G glycoprotein.
Journal of leukocyte biology 2008;84(3):748-59.
2008: Wei Shi; Yue Huang; Mark Sutton-Smith; Berangere Tissot; Maria Panico; Howard R Morris; Anne Dell; Stuart M Haslam; Jeffrey Boyington; Barney S Graham; Zhi-Yong Yang; Gary Nabel
A filovirus-unique region of Ebola virus nucleoprotein confers aberrant migration and mediates its incorporation into virions.
Journal of virology 2008;82(13):6190-9.
2008: Steevenson Nelson; Christiane A Jost; Qinq Xu; Jessica Ess; Julie E Martin; Theodore Oliphant; Stephen S Whitehead; Anna P Durbin; Barney S Graham; Michael S Diamond; Theodore C Pierson
Maturation of West Nile virus modulates sensitivity to antibody-mediated neutralization.
PLoS pathogens 2008;4(5):e1000060.
2008: Peter L Collins; Barney S Graham
Viral and host factors in human respiratory syncytial virus pathogenesis.
Journal of virology 2008;82(5):2040-55.
2007: Julie E Martin; Theodore C Pierson; Sarah Hubka; Steve Rucker; Ingelise J Gordon; Mary E Enama; Charla A Andrews; Qing Xu; Brent S Davis; Martha Nason; Michael Fay; Richard A Koup; Mario Roederer; Robert T Bailer; Phillip L Gomez; John R Mascola; Gwong-Jen J Chang; Gary Nabel; Barney S Graham
A West Nile virus DNA vaccine induces neutralizing antibody in healthy adults during a phase 1 clinical trial.
The Journal of infectious diseases 2007;196(12):1732-40.
2007: Michael A Eller; Leigh Anne Eller; Marc S Opollo; Benson J Ouma; Peter Ouma Oballah; Lynee Galley; Chitraporn Karnasuta; Silvia Ratto Kim; Merlin L Robb; Nelson L Michael; Hannah Kibuuka; Fred Wabwire-Mangen; Barney S Graham; Deborah L Birx; Mark de Souza; Josephine H Cox
Induction of HIV-specific functional immune responses by a multiclade HIV-1 DNA vaccine candidate in healthy Ugandans.
Vaccine 2007;25(45):7737-42.
2007: Melissa L Precopio; Michael R Betts; Janie Parrino; David A Price; Emma Gostick; David R Ambrozak; Tedi E Asher; Daniel C Douek; Alexandre Harari; Giuseppe Pantaleo; Robert T Bailer; Barney S Graham; Mario Roederer; Richard A Koup
Immunization with vaccinia virus induces polyfunctional and phenotypically distinctive CD8(+) T cell responses.
The Journal of experimental medicine 2007;204(6):1405-16.
2007: John A Rutigliano; Tracy J Ruckwardt; Julie E Martin; Barney S Graham
Relative dominance of epitope-specific CD8+ T cell responses in an F1 hybrid mouse model of respiratory syncytial virus infection.
Virology 2007;362(2):314-9.
2007: Andrew T Catanzaro; Mario Roederer; Richard A Koup; Robert T Bailer; Mary E Enama; Martha C Nason; Julie E Martin; Steve Rucker; Charla A Andrews; Phillip L Gomez; John R Mascola; Gary Nabel; Barney S Graham
Phase I clinical evaluation of a six-plasmid multiclade HIV-1 DNA candidate vaccine.
Vaccine 2007;25(20):4085-92.
2007: Jorge A Tavel; Julie E Martin; Grace G Kelly; Mary E Enama; Jean M Shen; Phillip L Gomez; Charla A Andrews; Richard A Koup; Robert T Bailer; Judy A Stein; Mario Roederer; Gary Nabel; Barney S Graham
Safety and immunogenicity of a Gag-Pol candidate HIV-1 DNA vaccine administered by a needle-free device in HIV-1-seronegative subjects.
Journal of acquired immune deficiency syndromes (1999) 2007;44(5):601-5.
2007: Janie Parrino; Lewis H McCurdy; Brenda D Larkin; Ingelise J Gordon; Steven E Rucker; Mary E Enama; Richard A Koup; Mario Roederer; Robert T Bailer; Zoe Moodie; Lin Gu; Lihan Yan; Barney S Graham
Safety, immunogenicity and efficacy of modified vaccinia Ankara (MVA) against Dryvax challenge in vaccinia-naïve and vaccinia-immune individuals.
Vaccine 2007;25(8):1513-25.
2007: Nina D Russell; Barney S Graham; Michael C Keefer; M Juliana McElrath; Steven G Self; Kent J Weinhold; David C Montefiori; Guido Ferrari; Helen Horton; Georgia D Tomaras; Sanjay Gurunathan; Lynn Baglyos; Sharon E Frey; Mark MULLIGAN; Clayton D Harro; Susan P Buchbinder; Lindsey R Baden; William A Blattner; Beryl A Koblin; Lawrence Corey
Phase 2 study of an HIV-1 canarypox vaccine (vCP1452) alone and in combination with rgp120: negative results fail to trigger a phase 3 correlates trial.
Journal of acquired immune deficiency syndromes (1999) 2007;44(2):203-12.
2007: Joyce E Johnson; Ricardo A Gonzales; Sandra J Olson; Peter F Wright; Barney S Graham
The histopathology of fatal untreated human respiratory syncytial virus infection.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2007;20(1):108-19.
2006: Barney S Graham; Richard A Koup; Mario Roederer; Robert T Bailer; Mary E Enama; Zoe Moodie; Julie E Martin; Margaret M McCluskey; Bimal K Chakrabarti; Laurie Lamoreaux; Charla A Andrews; Phillip L Gomez; John R Mascola; Gary Nabel
Phase 1 safety and immunogenicity evaluation of a multiclade HIV-1 DNA candidate vaccine.
The Journal of infectious diseases 2006;194(12):1650-60.
2006: Andrew T Catanzaro; Richard A Koup; Mario Roederer; Robert T Bailer; Mary E Enama; Zoe Moodie; Lin Gu; Julie E Martin; Laura Novik; Bimal K Chakrabarti; Bryan Butman; Jason G D Gall; C Richter King; Charla A Andrews; Rebecca L Sheets; Phillip L Gomez; John R Mascola; Gary Nabel; Barney S Graham
Phase 1 safety and immunogenicity evaluation of a multiclade HIV-1 candidate vaccine delivered by a replication-defective recombinant adenovirus vector.
The Journal of infectious diseases 2006;194(12):1638-49.
2006: Janie Parrino; Barney S Graham
Smallpox vaccines: Past, present, and future.
The Journal of allergy and clinical immunology 2006;118(6):1320-6.
2006: Weisong Zhou; Koichi Hashimoto; Martin L Moore; Jack A Elias; Zhou Zhu; Joan Durbin; Giuseppe N Colasurdo; John A Rutigliano; Constance L Chiappetta; Kasia Goleniewska; Jamye F O'Neal; Barney S Graham; R Stokes Peebles
IL-13 is associated with reduced illness and replication in primary respiratory syncytial virus infection in the mouse.
Microbes and infection / Institut Pasteur 2006;8(14-15):2880-9.
2006: Julie E Martin; Nancy J Sullivan; Mary E Enama; Ingelise J Gordon; Mario Roederer; Richard A Koup; Robert T Bailer; Bimal K Chakrabarti; Michael A Bailey; Phillip L Gomez; Charla A Andrews; Zoe Moodie; Lin Gu; Judith A Stein; Gary Nabel; Barney S Graham
A DNA vaccine for Ebola virus is safe and immunogenic in a phase I clinical trial.
Clinical and vaccine immunology : CVI 2006;13(11):1267-77.
2006: Jean-Michel Heraud; Yvette Edghill Spano; Victor Ayala; Irene Kalisz; Janie Parrino; Vaniambadi S Kalyanaraman; Jody Manischewitz; Lisa R King; Anna Hryniewicz; Christopher J Trindade; Meredith Hassett; Wen-Po Tsai; David Venzon; Aysegul Nalca; Monica Vaccari; Peter Silvera; Mike Bray; Barney S Graham; Hana Golding; Jay W Hooper; Genoveffa Franchini
Subunit recombinant vaccine protects against monkeypox.
Journal of immunology (Baltimore, Md. : 1950) 2006;177(4):2552-64.
2006: Surender Khurana; James Needham; Bonnie Mathieson; Isaac R Rodriguez-Chavez; Andrew T Catanzaro; Robert T Bailer; Jerome Kim; Vicky Polonis; David A Cooper; Jan Guerin; Michael L Peterson; Marc Gurwith; Nga Nguyen; Barney S Graham; Hana Golding
Human immunodeficiency virus (HIV) vaccine trials: a novel assay for differential diagnosis of HIV infections in the face of vaccine-generated antibodies.
Journal of virology 2006;80(5):2092-9.
2006: Barney S Graham
New approaches to vaccine adjuvants: inhibiting the inhibitor.
PLoS medicine 2006;3(1):e57.
2005: R Stokes Peebles; Koichi Hashimoto; James R Sheller; Martin L Moore; Jason D Morrow; Shaoquan Ji; Jack A Elias; Kasia Goleniewska; Jamye F O'Neal; Daphne B Mitchell; Barney S Graham; Weisong Zhou
Allergen-induced airway hyperresponsiveness mediated by cyclooxygenase inhibition is not dependent on 5-lipoxygenase or IL-5, but is IL-13 dependent.
Journal of immunology (Baltimore, Md. : 1950) 2005;175(12):8253-9.
2005: Koichi Hashimoto; Joan E Durbin; Weisong Zhou; Robert D Collins; Samuel B Ho; Jay K Kolls; Patricia J Dubin; James R Sheller; Kasia Goleniewska; Jamye F O'Neal; Sandra J Olson; Daphne Mitchell; Barney S Graham; R Stokes Peebles
Respiratory syncytial virus infection in the absence of STAT 1 results in airway dysfunction, airway mucus, and augmented IL-17 levels.
The Journal of allergy and clinical immunology 2005;116(3):550-7.
2005: John A Rutigliano; Michael T Rock; Amanda K Johnson; James Crowe; Barney S Graham
Identification of an H-2D(b)-restricted CD8+ cytotoxic T lymphocyte epitope in the matrix protein of respiratory syncytial virus.
Virology 2005;337(2):335-43.
2005: tara gower; Manoj K Pastey; Mark Peeples; Peter L Collins; Lewis H McCurdy; Timothy K Hart; Alex Guth; Teresa Johnson; Barney S Graham
RhoA signaling is required for respiratory syncytial virus-induced syncytium formation and filamentous virion morphology.
Journal of virology 2005;79(9):5326-36.
2005: Barney S Graham; John R Mascola
Lessons from failure--preparing for future HIV-1 vaccine efficacy trials.
The Journal of infectious diseases 2005;191(5):647-9.
2005: R Stokes Peebles; Barney S Graham
Pathogenesis of respiratory syncytial virus infection in the murine model.
Proceedings of the American Thoracic Society 2005;2(2):110-5.
2005: Koichi Hashimoto; James R Sheller; Jason D Morrow; Robert D Collins; Kasia Goleniewska; Jamye F O'Neal; Weisong Zhou; Shaoquan Ji; Daphne B Mitchell; Barney S Graham; R Stokes Peebles
Cyclooxygenase inhibition augments allergic inflammation through CD4-dependent, STAT6-independent mechanisms.
Journal of immunology (Baltimore, Md. : 1950) 2005;174(1):525-32.
2004: Alexander C Schmidt; Teresa Johnson; Peter J M Openshaw; Thomas J Braciale; Ann R Falsey; Lawrence J Anderson; Gail W Wertz; Jessie R Groothuis; Gregory A Prince; José A Melero; Barney S Graham
Respiratory syncytial virus and other pneumoviruses: a review of the international symposium--RSV 2003.
Virus research 2004;106(1):1-13.
2004: Lewis H McCurdy; John A Rutigliano; Teresa Johnson; Man Chen; Barney S Graham
Modified vaccinia virus Ankara immunization protects against lethal challenge with recombinant vaccinia virus expressing murine interleukin-4.
Journal of virology 2004;78(22):12471-9.
2004: Koichi Hashimoto; Barney S Graham; Mark W Geraci; garret fitzgerald; Karine Egan; Weisong Zhou; Kasia Goleniewska; Jamye F O'Neal; Jason D Morrow; Russell K Durbin; Peter F Wright; Robert D Collins; Tatsuo Suzutani; R Stokes Peebles
Signaling through the prostaglandin I2 receptor IP protects against respiratory syncytial virus-induced illness.
Journal of virology 2004;78(19):10303-9.
2004: John A Rutigliano; Barney S Graham
Prolonged production of TNF-alpha exacerbates illness during respiratory syncytial virus infection.
Journal of immunology (Baltimore, Md. : 1950) 2004;173(5):3408-17.
2004: Deborah Lee; Barney S Graham; Ya-Lin Chiu; Peter B Gilbert; M Juliana McElrath; Robert B Belshe; Susan P Buchbinder; Haynes W Sheppard; Beryl A Koblin; Kenneth H Mayer; Michael C Keefer; Mark MULLIGAN; Connie Celum
Breakthrough infections during phase 1 and 2 prime-boost HIV-1 vaccine trials with canarypox vectors (ALVAC) and booster dose of recombinant gp120 or gp160.
The Journal of infectious diseases 2004;190(5):903-7.
2004: Teresa Johnson; Steven M Varga; Thomas J Braciale; Barney S Graham
Vbeta14(+) T cells mediate the vaccine-enhanced disease induced by immunization with respiratory syncytial virus (RSV) G glycoprotein but not with formalin-inactivated RSV.
Journal of virology 2004;78(16):8753-60.
2004: Philip J Budge; Barney S Graham
Inhibition of respiratory syncytial virus by RhoA-derived peptides: implications for the development of improved antiviral agents targeting heparin-binding viruses.
The Journal of antimicrobial chemotherapy 2004;54(2):299-302.
2004: Koichi Hashimoto; Barney S Graham; Samuel B Ho; Kenneth B Adler; Robert D Collins; Sandra J Olson; Weisong Zhou; Tatsuo Suzutani; Phillip W Jones; Kasia Goleniewska; Jamye F O'Neal; R Stokes Peebles
Respiratory syncytial virus in allergic lung inflammation increases Muc5ac and gob-5.
American journal of respiratory and critical care medicine 2004;170(3):306-12.
2004: Lewis H McCurdy; Brenda D Larkin; Julie E Martin; Barney S Graham
Modified vaccinia Ankara: potential as an alternative smallpox vaccine.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2004;38(12):1749-53.
2004: Teresa Johnson; Michael N Teng; Peter L Collins; Barney S Graham
Respiratory syncytial virus (RSV) G glycoprotein is not necessary for vaccine-enhanced disease induced by immunization with formalin-inactivated RSV.
Journal of virology 2004;78(11):6024-32.
2004: Philip J Budge; Yeqiang Li; Judy A Beeler; Barney S Graham
RhoA-derived peptide dimers share mechanistic properties with other polyanionic inhibitors of respiratory syncytial virus (RSV), including disruption of viral attachment and dependence on RSV G.
Journal of virology 2004;78(10):5015-22.
2004: John A Rutigliano; Teresa Johnson; Tonya N Hollinger; Julie E Fischer; Sandra Aung; Barney S Graham
Treatment with anti-LFA-1 delays the CD8+ cytotoxic-T-lymphocyte response and viral clearance in mice with primary respiratory syncytial virus infection.
Journal of virology 2004;78(6):3014-23.
2004: Teresa Johnson; Barney S Graham
Contribution of respiratory syncytial virus G antigenicity to vaccine-enhanced illness and the implications for severe disease during primary respiratory syncytial virus infection.
The Pediatric infectious disease journal 2004;23(1 Suppl):S46-57.
2003: Philip J Budge; Jacob Lebowitz; Barney S Graham
Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers.
Antimicrobial agents and chemotherapy 2003;47(11):3470-7.
2003: Yi-Wei Tang; Joyce E Johnson; Philip J Browning; Roberto Cruz-Gervis; Angela Davis; Barney S Graham; Kenneth L Brigham; John A Oates; James E Loyd; Arlene A Stecenko
Herpesvirus DNA is consistently detected in lungs of patients with idiopathic pulmonary fibrosis.
Journal of clinical microbiology 2003;41(6):2633-40.
2003: Teresa Johnson; Robert A Parker; Joyce E Johnson; Barney S Graham
IL-13 is sufficient for respiratory syncytial virus G glycoprotein-induced eosinophilia after respiratory syncytial virus challenge.
Journal of immunology (Baltimore, Md. : 1950) 2003;170(4):2037-45.
2003: Lewis H McCurdy; Barney S Graham
Role of plasma membrane lipid microdomains in respiratory syncytial virus filament formation.
Journal of virology 2003;77(3):1747-56.
2003: R Stokes Peebles; Koichi Hashimoto; Barney S Graham
The complex relationship between respiratory syncytial virus and allergy in lung disease.
Viral immunology 2003;16(1):25-34.
2002: Chun Geun Lee; Robert J Homer; Lauren Cohn; Holger W Link; Sungsoo Jung; Joseph E Craft; Barney S Graham; Teresa Johnson; Jack A Elias
Transgenic overexpression of interleukin (IL)-10 in the lung causes mucus metaplasia, tissue inflammation, and airway remodeling via IL-13-dependent and -independent pathways.
The Journal of biological chemistry 2002;277(38):35466-74.
2002: Koichi Hashimoto; R Stokes Peebles; James R Sheller; Kasia Jarzecka; Jamye Furlong; Daphne B Mitchell; Tina V Hartert; Barney S Graham
Suppression of airway hyperresponsiveness induced by ovalbumin sensitisation and RSV infection with Y-27632, a Rho kinase inhibitor.
Thorax 2002;57(6):524-7.
2002: Barney S Graham; John A Rutigliano; Teresa Johnson
Respiratory syncytial virus immunobiology and pathogenesis.
Virology 2002;297(1):1-7.
2002: Teresa Johnson; Seokmann Hong; Luc Van Kaer; Yasuhiko Koezuka; Barney S Graham
NK T cells contribute to expansion of CD8(+) T cells and amplification of antiviral immune responses to respiratory syncytial virus.
Journal of virology 2002;76(9):4294-303.
2002: R Stokes Peebles; Koichi Hashimoto; Jason D Morrow; Ryszard Dworski; Robert D Collins; Yuko Hashimoto; John W Christman; Kyung-Ho Kang; Kasia Jarzecka; Jamye Furlong; Daphne B Mitchell; Megha Talati; Barney S Graham; James R Sheller
Selective cyclooxygenase-1 and -2 inhibitors each increase allergic inflammation and airway hyperresponsiveness in mice.
American journal of respiratory and critical care medicine 2002;165(8):1154-60.
2002: Peter F Wright; William C Gruber; Melissa Peters; George Reed; Yuwei Zhu; Frances Robinson; Shanita Coleman-Dockery; Barney S Graham
Illness severity, viral shedding, and antibody responses in infants hospitalized with bronchiolitis caused by respiratory syncytial virus.
The Journal of infectious diseases 2002;185(8):1011-8.
2002: Joan E Durbin; Teresa Johnson; Russell K Durbin; Sara E Mertz; Rafaella A Morotti; R Stokes Peebles; Barney S Graham
The role of IFN in respiratory syncytial virus pathogenesis.
Journal of immunology (Baltimore, Md. : 1950) 2002;168(6):2944-52.
2002: Barney S Graham
Clinical trials of HIV vaccines.
Annual review of medicine 2002;53():207-21.
2001: R Stokes Peebles; Koichi Hashimoto; Robert D Collins; Kasia Jarzecka; Jamye Furlong; Daphne B Mitchell; James R Sheller; Barney S Graham
Immune interaction between respiratory syncytial virus infection and allergen sensitization critically depends on timing of challenges.
The Journal of infectious diseases 2001;184(11):1374-9.
2001: Sandra Aung; John A Rutigliano; Barney S Graham
Alternative mechanisms of respiratory syncytial virus clearance in perforin knockout mice lead to enhanced disease.
Journal of virology 2001;75(20):9918-24.
2001: Teresa Johnson; Julie E Fischer; Barney S Graham
Construction and characterization of recombinant vaccinia viruses co-expressing a respiratory syncytial virus protein and a cytokine.
The Journal of general virology 2001;82(Pt 9):2107-16.
2001: tara gower; Mark Peeples; Peter L Collins; Barney S Graham
RhoA is activated during respiratory syncytial virus infection.
Virology 2001;283(2):188-96.
2001: tara gower; Barney S Graham
Antiviral activity of lovastatin against respiratory syncytial virus in vivo and in vitro.
Antimicrobial agents and chemotherapy 2001;45(4):1231-7.
2001: Thomas G Evans; M Juliana McElrath; T Matthews; David Montefiori; Kent J Weinhold; Mark Wolff; Michael C Keefer; Esper Kallas; Lawrence Corey; Geoffrey J Gorse; Robert B Belshe; Barney S Graham; Paul Spearman; David H Schwartz; Mark MULLIGAN; Paul A Goepfert; Patricia Fast; Phillip W. Berman; M Powell; D Francis
QS-21 promotes an adjuvant effect allowing for reduced antigen dose during HIV-1 envelope subunit immunization in humans.
Vaccine 2001;19(15-16):2080-91.
2001: R Stokes Peebles; James R Sheller; Robert D Collins; A K Jarzecka; Daphne B Mitchell; RA Parker; Barney S Graham
Respiratory syncytial virus infection does not increase allergen-induced type 2 cytokine production, yet increases airway hyperresponsiveness in mice.
Journal of medical virology 2001;63(2):178-88.
2000: Julie E Fischer; Joyce E Johnson; Teresa Johnson; Barney S Graham
Pertussis toxin sensitization alters the pathogenesis of subsequent respiratory syncytial virus infection.
The Journal of infectious diseases 2000;182(4):1029-38.
2000: R Stokes Peebles; James R Sheller; Robert D Collins; Kasia Jarzecka; Daphne B Mitchell; Barney S Graham
Respiratory syncytial virus (RSV)-induced airway hyperresponsiveness in allergically sensitized mice is inhibited by live RSV and exacerbated by formalin-inactivated RSV.
The Journal of infectious diseases 2000;182(3):671-7.
2000: R Stokes Peebles; Ryszard Dworski; Robert D Collins; Kasia Jarzecka; Daphne B Mitchell; Barney S Graham; James R Sheller
Cyclooxygenase inhibition increases interleukin 5 and interleukin 13 production and airway hyperresponsiveness in allergic mice.
American journal of respiratory and critical care medicine 2000;162(2 Pt 1):676-81.
2000: Barney S Graham; Teresa Johnson; R Stokes Peebles
Immune-mediated disease pathogenesis in respiratory syncytial virus infection.
Immunopharmacology 2000;48(3):237-47.
2000: M Juliana McElrath; Lawrence Corey; David Montefiori; Mark Wolff; David H Schwartz; Michael C Keefer; Robert B Belshe; Barney S Graham; T Matthews; P Wright; Geoffrey J Gorse; Raphael Dolin; Phillip W. Berman; D Francis; AM Duliege; Dani P Bolognesi; Donald Stablein; N Ketter; Patricia Fast
A phase II study of two HIV type 1 envelope vaccines, comparing their immunogenicity in populations at risk for acquiring HIV type 1 infection. AIDS Vaccine Evaluation Group.
AIDS research and human retroviruses 2000;16(9):907-19.
2000: Sandra Aung; Barney S Graham
IL-4 diminishes perforin-mediated and increases Fas ligand-mediated cytotoxicity In vivo.
Journal of immunology (Baltimore, Md. : 1950) 2000;164(7):3487-93.
2000: Manoj K Pastey; tara gower; Paul Spearman; James Crowe; Barney S Graham
A RhoA-derived peptide inhibits syncytium formation induced by respiratory syncytial virus and parainfluenza virus type 3.
Nature medicine 2000;6(1):35-40.
1999: Sandra Aung; Yi-Wei Tang; Barney S Graham
Interleukin-4 diminishes CD8(+) respiratory syncytial virus-specific cytotoxic T-lymphocyte activity in vivo.
Journal of virology 1999;73(11):8944-9.
1999: Teresa Johnson; Barney S Graham
Secreted respiratory syncytial virus G glycoprotein induces interleukin-5 (IL-5), IL-13, and eosinophilia by an IL-4-independent mechanism.
Journal of virology 1999;73(10):8485-95.
1999: Manoj K Pastey; James Crowe; Barney S Graham
RhoA interacts with the fusion glycoprotein of respiratory syncytial virus and facilitates virus-induced syncytium formation.
Journal of virology 1999;73(9):7262-70.
1999: Julie E Fischer; Teresa Johnson; R Stokes Peebles; Barney S Graham
Vaccination with pertussis toxin alters the antibody response to simultaneous respiratory syncytial virus challenge.
The Journal of infectious diseases 1999;180(3):714-9.
1999: RG Fisher; Joyce E Johnson; S B Dillon; RA Parker; Barney S Graham
Prophylaxis with respiratory syncytial virus F-specific humanized monoclonal antibody delays and moderately suppresses the native antibody response but does not impair immunity to late rechallenge.
The Journal of infectious diseases 1999;180(3):708-13.
1999: Thomas G Evans; Michael C Keefer; Kent J Weinhold; Mark Wolff; David Montefiori; Geoffrey J Gorse; Barney S Graham; M Juliana McElrath; Mary Lou Clements-Mann; Mark MULLIGAN; Patricia Fast; MC Walker; Jean-Louis Excler; AM Duliege; Jim Tartaglia
A canarypox vaccine expressing multiple human immunodeficiency virus type 1 genes given alone or with rgp120 elicits broad and durable CD8+ cytotoxic T lymphocyte responses in seronegative volunteers.
The Journal of infectious diseases 1999;180(2):290-8.
1999: R Stokes Peebles; James R Sheller; Joyce E Johnson; Daphne B Mitchell; Barney S Graham
Respiratory syncytial virus infection prolongs methacholine-induced airway hyperresponsiveness in ovalbumin-sensitized mice.
Journal of medical virology 1999;57(2):186-92.
1998: Mary Lou Clements-Mann; Kent J Weinhold; TJ Matthews; Barney S Graham; Geoffrey J Gorse; Michael C Keefer; M Juliana McElrath; RH Hsieh; Jiri Mestecky; Susan Zolla-Pazner; J Mascola; David H Schwartz; Robert Siliciano; Lawrence Corey; Peter F Wright; Robert B Belshe; Raphael Dolin; S Jackson; S Xu; Patricia Fast; MC Walker; Donald Stablein; Jean-Louis Excler; Jim Tartaglia; E Paoletti
Immune responses to human immunodeficiency virus (HIV) type 1 induced by canarypox expressing HIV-1MN gp120, HIV-1SF2 recombinant gp120, or both vaccines in seronegative adults. NIAID AIDS Vaccine Evaluation Group.
The Journal of infectious diseases 1998;177(5):1230-46.
1998: Teresa Johnson; Joyce E Johnson; S R Roberts; GW Wertz; RA Parker; Barney S Graham
Priming with secreted glycoprotein G of respiratory syncytial virus (RSV) augments interleukin-5 production and tissue eosinophilia after RSV challenge.
Journal of virology 1998;72(4):2871-80.
1998: Barney S Graham; M Juliana McElrath; Ruth I Connor; David H Schwartz; Geoffrey J Gorse; Michael C Keefer; Mark MULLIGAN; TJ Matthews; Steven Wolinsky; David C Montefiori; Sten Vermund; John S Lambert; Lawrence Corey; Robert B Belshe; Raphael Dolin; Peter F Wright; Bette T Korber; M C Wolff; Patricia Fast
Analysis of intercurrent human immunodeficiency virus type 1 infections in phase I and II trials of candidate AIDS vaccines. AIDS Vaccine Evaluation Group, and the Correlates of HIV Immune Protection Group.
The Journal of infectious diseases 1998;177(2):310-9.
1998: Ruth I Connor; Bette T Korber; Barney S Graham; B H Hahn; David D Ho; B D Walker; Avidan U Neumann; Sten Vermund; J Mestecky; S Jackson; E Fenamore; Yunzhen Cao; F Gao; S Kalams; Kevin Kunstman; D McDonald; N McWilliams; Alexandra Trkola; John P Moore; Steven Wolinsky
Immunological and virological analyses of persons infected by human immunodeficiency virus type 1 while participating in trials of recombinant gp120 subunit vaccines.
Journal of virology 1998;72(2):1552-76.
1997: Julie E Fischer; Joyce E Johnson; R K Kuli-Zade; Teresa Johnson; Sandra Aung; RA Parker; Barney S Graham
Overexpression of interleukin-4 delays virus clearance in mice infected with respiratory syncytial virus.
Journal of virology 1997;71(11):8672-7.
1997: Michael C Keefer; Mark Wolff; Geoffrey J Gorse; Barney S Graham; Lawrence Corey; Mary Lou Clements-Mann; N Verani-Ketter; S Erb; C M Smith; Robert B Belshe; LJ Wagner; M Juliana McElrath; David H Schwartz; Patricia Fast
Safety profile of phase I and II preventive HIV type 1 envelope vaccination: experience of the NIAID AIDS Vaccine Evaluation Group.
AIDS research and human retroviruses 1997;13(14):1163-77.
1997: Yi-Wei Tang; Barney S Graham
T cell source of type 1 cytokines determines illness patterns in respiratory syncytial virus-infected mice.
The Journal of clinical investigation 1997;99(9):2183-91.
1997: Yi-Wei Tang; Kathleen M Neuzil; Julie E Fischer; F W Robinson; RA Parker; Barney S Graham
Determinants and kinetics of cytokine expression patterns in lungs of vaccinated mice challenged with respiratory syncytial virus.
Vaccine 1997;15(6-7):597-602.
1997: Kathleen M Neuzil; Joyce E Johnson; Yi-Wei Tang; jean-paul prieels; Moncef Slaoui; N Gar; Barney S Graham
Adjuvants influence the quantitative and qualitative immune response in BALB/c mice immunized with respiratory syncytial virus FG subunit vaccine.
Vaccine 1997;15(5):525-32.
1997: Kathleen M Neuzil; William C Gruber; Barney S Graham
Vitamin A therapy for respiratory syncytial virus infection.
The Pediatric infectious disease journal 1997;16(1):84-5.
1996: Barney S Graham; Michael C Keefer; M Juliana McElrath; Geoffrey J Gorse; David H Schwartz; Kent J Weinhold; TJ Matthews; J R Esterlitz; F Sinangil; Patricia Fast
Safety and immunogenicity of a candidate HIV-1 vaccine in healthy adults: recombinant glycoprotein (rgp) 120. A randomized, double-blind trial. NIAID AIDS Vaccine Evaluation Group.
Annals of internal medicine 1996;125(4):270-9.
1996: Barney S Graham
Immunological determinants of disease caused by respiratory syncytial virus.
Trends in microbiology 1996;4(7):290-3.
1996: C Lindgren; J Lin; Barney S Graham; M E Gray; RA Parker; Håkan W Sundell
Respiratory syncytial virus infection enhances the response to laryngeal chemostimulation and inhibits arousal from sleep in young lambs.
Acta paediatrica (Oslo, Norway : 1992) 1996;85(7):789-97.
1996: Michael C Keefer; Barney S Graham; M Juliana McElrath; TJ Matthews; Donald Stablein; Lawrence Corey; Peter F Wright; D Lawrence; Patricia Fast; Kent J Weinhold; RH Hsieh; David Chernoff; C Dekker; Raphael Dolin
Safety and immunogenicity of Env 2-3, a human immunodeficiency virus type 1 candidate vaccine, in combination with a novel adjuvant, MTP-PE/MF59. NIAID AIDS Vaccine Evaluation Group.
AIDS research and human retroviruses 1996;12(8):683-93.
1996: Kathleen M Neuzil; Yi-Wei Tang; Barney S Graham
Protective Role of TNF-alpha in respiratory syncytial virus infection in vitro and in vivo.
The American journal of the medical sciences 1996;311(5):201-4.
1996: John R Mascola; Stuart Snyder; O S Weislow; S M Belay; Robert B Belshe; David H Schwartz; M L Clements; Raphael Dolin; Barney S Graham; Geoffrey J Gorse; Michael C Keefer; M Juliana McElrath; MC Walker; K F Wagner; John G McNeil; Francine E McCutchan; Donald S. Burke
Immunization with envelope subunit vaccine products elicits neutralizing antibodies against laboratory-adapted but not primary isolates of human immunodeficiency virus type 1. The National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group.
The Journal of infectious diseases 1996;173(2):340-8.
1995: Barney S Graham; Peter F Wright
Candidate AIDS vaccines.
The New England journal of medicine 1995;333(20):1331-9.
1995: Barney S Graham
Pathogenesis of respiratory syncytial virus vaccine-augmented pathology.
American journal of respiratory and critical care medicine 1995;152(4 Pt 2):S63-6.
1995: Yi-Wei Tang; Barney S Graham
Interleukin-12 treatment during immunization elicits a T helper cell type 1-like immune response in mice challenged with respiratory syncytial virus and improves vaccine immunogenicity.
The Journal of infectious diseases 1995;172(3):734-8.
1995: Barney S Graham; Yi-Wei Tang; William C Gruber
Topical immunoprophylaxis of respiratory syncytial virus (RSV)-challenged mice with RSV-specific immune globulin.
The Journal of infectious diseases 1995;171(6):1468-74.
1995: Kathleen M Neuzil; William C Gruber; F Chytil; Mildred T Stahlman; Barney S Graham
Safety and pharmacokinetics of vitamin A therapy for infants with respiratory syncytial virus infections.
Antimicrobial agents and chemotherapy 1995;39(5):1191-3.
1994: Kathleen M Neuzil; Holly C Mitchell; James E Loyd; C F Lagerstrom; J W Hammon; Barney S Graham
Extrapulmonary thoracic disease caused by Blastomyces dermatitidis.
Chest 1994;106(6):1885-7.
1994: Michael C Keefer; Barney S Graham; Robert B Belshe; David H Schwartz; Lawrence Corey; Dani P Bolognesi; Donald Stablein; D C Montefiori; M Juliana McElrath; M L Clements
Studies of high doses of a human immunodeficiency virus type 1 recombinant glycoprotein 160 candidate vaccine in HIV type 1-seronegative humans. The AIDS Vaccine Clinical Trials Network.
AIDS research and human retroviruses 1994;10(12):1713-23.
1994: Yi-Wei Tang; Barney S Graham
Anti-IL-4 treatment at immunization modulates cytokine expression, reduces illness, and increases cytotoxic T lymphocyte activity in mice challenged with respiratory syncytial virus.
The Journal of clinical investigation 1994;94(5):1953-8.
1994: Robert B Belshe; M L Clements; Michael C Keefer; Barney S Graham; L Corey; R Sposto; S Wescott; D Lawrence
Interpreting HIV serodiagnostic test results in the 1990s: social risks of HIV vaccine studies in uninfected volunteers. NIAID AIDS Vaccine Clinical Trials Group.
Annals of internal medicine 1994;121(8):584-9.
1994: Barney S Graham; Geoffrey J Gorse; David H Schwartz; Michael C Keefer; M Juliana McElrath; TJ Matthews; Peter F Wright; Robert B Belshe; M L Clements; Raphael Dolin
Determinants of antibody response after recombinant gp160 boosting in vaccinia-naive volunteers primed with gp160-recombinant vaccinia virus. The National Institute of Allergy and Infectious Diseases AIDS Vaccine Clinical Trials Network.
The Journal of infectious diseases 1994;170(4):782-6.
1994: Robert B Belshe; Barney S Graham; Michael C Keefer; Geoffrey J Gorse; P Wright; Raphael Dolin; T Matthews; Kent J Weinhold; Dani P Bolognesi; R Sposto
Neutralizing antibodies to HIV-1 in seronegative volunteers immunized with recombinant gp120 from the MN strain of HIV-1. NIAID AIDS Vaccine Clinical Trials Network.
JAMA : the journal of the American Medical Association 1994;272(6):475-80.
1994: Kathleen M Neuzil; William C Gruber; F Chytil; Mildred T Stahlman; B Engelhardt; Barney S Graham
Serum vitamin A levels in respiratory syncytial virus infection.
The Journal of pediatrics 1994;124(3):433-6.
1994: Barney S Graham
Serological responses to candidate AIDS vaccines.
AIDS research and human retroviruses 1994;10 Suppl 2():S145-8.
1993: Robert B Belshe; M L Clements; Raphael Dolin; Barney S Graham; J McElrath; Geoffrey J Gorse; David H Schwartz; Michael C Keefer; P Wright; L Corey
Safety and immunogenicity of a fully glycosylated recombinant gp160 human immunodeficiency virus type 1 vaccine in subjects at low risk of infection. National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group Network.
The Journal of infectious diseases 1993;168(6):1387-95.
1993: Barney S Graham; G S Henderson; Yi-Wei Tang; X Lu; Kathleen M Neuzil; Daniel G Colley
Priming immunization determines T helper cytokine mRNA expression patterns in lungs of mice challenged with respiratory syncytial virus.
Journal of immunology (Baltimore, Md. : 1950) 1993;151(4):2032-40.
1993: D C Montefiori; Barney S Graham; J Zhou; J Zhou; R A Bucco; David H Schwartz; Lisa A Cavacini; Marshall R Posner
V3-specific neutralizing antibodies in sera from HIV-1 gp160-immunized volunteers block virus fusion and act synergistically with human monoclonal antibody to the conformation-dependent CD4 binding site of gp120. NIH-NIAID AIDS Vaccine Clinical Trials Network.
The Journal of clinical investigation 1993;92(2):840-7.
1993: Barney S Graham; T H Davis; Yi-Wei Tang; William C Gruber
Immunoprophylaxis and immunotherapy of respiratory syncytial virus-infected mice with respiratory syncytial virus-specific immune serum.
Pediatric research 1993;34(2):167-72.
1993: Barney S Graham; TJ Matthews; Robert B Belshe; M L Clements; Raphael Dolin; Peter F Wright; Geoffrey J Gorse; David H Schwartz; Michael C Keefer; Dani P Bolognesi
Augmentation of human immunodeficiency virus type 1 neutralizing antibody by priming with gp160 recombinant vaccinia and boosting with rgp160 in vaccinia-naive adults. The NIAID AIDS Vaccine Clinical Trials Network.
The Journal of infectious diseases 1993;167(3):533-7.
1993: Kathryn M Edwards; M D Decker; Barney S Graham; J Mezzatesta; J Scott; J Hackell
Adult immunization with acellular pertussis vaccine.
JAMA : the journal of the American Medical Association 1993;269(1):53-6.
1992: D C Montefiori; Barney S Graham; S Kliks; Peter F Wright
Serum antibodies to HIV-1 in recombinant vaccinia virus recipients boosted with purified recombinant gp160. NIAID AIDS Vaccine Clinical Trials Network.
Journal of clinical immunology 1992;12(6):429-39.
1992: C F Lagerstrom; Holly C Mitchell; Barney S Graham; J W Hammon
Chronic fibrosing mediastinitis and superior vena caval obstruction from blastomycosis.
The Annals of thoracic surgery 1992;54(4):764-5.
1992: H N Ukwu; Barney S Graham; John S Lambert; Peter F Wright
Perinatal transmission of human immunodeficiency virus-1 infection and maternal immunization strategies for prevention.
Obstetrics and gynecology 1992;80(3 Pt 1):458-68.
1992: Barney S Graham
Clinical trials of AIDS vaccines in seronegative volunteers: vectors and combinations.
AIDS research and human retroviruses 1992;8(8):1327-8.
1992: Barney S Graham; Robert B Belshe; M L Clements; Raphael Dolin; Lawrence Corey; Peter F Wright; Geoffrey J Gorse; K Midthun; Michael C Keefer; N J Roberts
Vaccination of vaccinia-naive adults with human immunodeficiency virus type 1 gp160 recombinant vaccinia virus in a blinded, controlled, randomized clinical trial. The AIDS Vaccine Clinical Trials Network.
The Journal of infectious diseases 1992;166(2):244-52.
1991: Barney S Graham; L A Bunton; Peter F Wright; D T Karzon
Role of T lymphocyte subsets in the pathogenesis of primary infection and rechallenge with respiratory syncytial virus in mice.
The Journal of clinical investigation 1991;88(3):1026-33.
1991: Barney S Graham; L A Bunton; J Rowland; Peter F Wright; D T Karzon
Respiratory syncytial virus infection in anti-mu-treated mice.
Journal of virology 1991;65(9):4936-42.
1991: Barney S Graham; L A Bunton; Peter F Wright; D T Karzon
Reinfection of mice with respiratory syncytial virus.
Journal of medical virology 1991;34(1):7-13.
1991: R Dolin; Barney S Graham; S B Greenberg; Carol O Tacket; Robert B Belshe; K Midthun; M L Clements; Geoffrey J Gorse; B W Horgan; Robert L Atmar
The safety and immunogenicity of a human immunodeficiency virus type 1 (HIV-1) recombinant gp160 candidate vaccine in humans. NIAID AIDS Vaccine Clinical Trials Network.
Annals of internal medicine 1991;114(2):119-27.
1990: Barney S Graham; J M Rowland; A Modliszewski; D C Montefiori
Antifusion activity in sera from persons infected with human immunodeficiency virus type 1.
Journal of clinical microbiology 1990;28(12):2608-11.
1990: Barney S Graham; N T Wetherall
Growth of human cell lines in BALB/c mice.
Cancer research 1990;50(18):5943-6.
1990: Barney S Graham; D T Karzon
Development of an AIDS vaccine. Biological and ethical challenges.
Infectious disease clinics of North America 1990;4(2):223-43.
1988: Barney S Graham; Mark Perkins; Peter F Wright; D T Karzon
Primary respiratory syncytial virus infection in mice.
Journal of medical virology 1988;26(2):153-62.